Meeder Asset Management Inc. Buys New Position in Everus (NYSE:ECG)

Meeder Asset Management Inc. purchased a new position in shares of Everus (NYSE:ECGFree Report) during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund purchased 64,878 shares of the company’s stock, valued at approximately $4,266,000.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Vanguard Group Inc. acquired a new position in shares of Everus during the fourth quarter valued at approximately $365,965,000. American Century Companies Inc. acquired a new stake in Everus in the fourth quarter worth approximately $49,650,000. Norges Bank bought a new position in Everus during the 4th quarter valued at $34,672,000. Hennessy Advisors Inc. acquired a new position in shares of Everus during the 4th quarter valued at $31,611,000. Finally, US Bancorp DE bought a new stake in shares of Everus in the 4th quarter worth $28,332,000.

Everus Stock Up 3.3 %

Shares of NYSE ECG opened at $36.11 on Monday. The company has a debt-to-equity ratio of 0.47, a current ratio of 1.58 and a quick ratio of 1.50. Everus has a 12 month low of $33.90 and a 12 month high of $77.93. The company’s fifty day moving average is $51.30.

Everus (NYSE:ECGGet Free Report) last posted its quarterly earnings data on Tuesday, February 11th. The company reported $0.67 EPS for the quarter, missing analysts’ consensus estimates of $0.73 by ($0.06). Equities research analysts forecast that Everus will post 2.49 EPS for the current year.

Analysts Set New Price Targets

Several brokerages recently weighed in on ECG. Wolfe Research started coverage on Everus in a research note on Tuesday, December 3rd. They set a “peer perform” rating for the company. Stifel Nicolaus lowered their price objective on shares of Everus from $85.00 to $67.00 and set a “buy” rating on the stock in a research note on Thursday, February 13th. Finally, Oppenheimer boosted their target price on shares of Everus from $70.00 to $80.00 and gave the stock an “outperform” rating in a report on Tuesday, January 7th.

View Our Latest Stock Analysis on ECG

Insider Buying and Selling

In other Everus news, Director Rocca Michael Della bought 1,050 shares of the firm’s stock in a transaction dated Tuesday, February 18th. The stock was acquired at an average price of $47.56 per share, with a total value of $49,938.00. Following the completion of the transaction, the director now directly owns 2,027 shares in the company, valued at approximately $96,404.12. This represents a 107.47 % increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CFO Maximillian J. Marcy purchased 1,300 shares of the stock in a transaction dated Tuesday, February 25th. The shares were acquired at an average price of $38.99 per share, for a total transaction of $50,687.00. Following the acquisition, the chief financial officer now directly owns 5,508 shares of the company’s stock, valued at $214,756.92. This represents a 30.89 % increase in their position. The disclosure for this purchase can be found here. In the last 90 days, insiders bought 3,750 shares of company stock valued at $153,853.

Everus Profile

(Free Report)

Everus Construction Group is providing a full spectrum of construction services through its electrical and mechanical and transmission and distribution specialty contracting services principally in United States. Its specialty contracting services are provided to utility, transportation, commercial, industrial, institutional, renewable and other customers.

Read More

Want to see what other hedge funds are holding ECG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Everus (NYSE:ECGFree Report).

Institutional Ownership by Quarter for Everus (NYSE:ECG)

Receive News & Ratings for Everus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Everus and related companies with MarketBeat.com's FREE daily email newsletter.